Compare MSN & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSN | SNOA |
|---|---|---|
| Founded | 1948 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 6.1M |
| IPO Year | 1995 | 2006 |
| Metric | MSN | SNOA |
|---|---|---|
| Price | $0.31 | $1.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 93.3K | 37.7K |
| Earning Date | 11-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.09 | ★ 32.26 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,829,000.00 | $19,529,000.00 |
| Revenue This Year | N/A | $22.44 |
| Revenue Next Year | N/A | $12.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.68 |
| 52 Week Low | $0.30 | $0.85 |
| 52 Week High | $0.55 | $3.95 |
| Indicator | MSN | SNOA |
|---|---|---|
| Relative Strength Index (RSI) | 28.04 | 38.98 |
| Support Level | N/A | $1.03 |
| Resistance Level | $0.39 | $1.29 |
| Average True Range (ATR) | 0.02 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 14.15 | 22.23 |
Emerson Radio Corp designs, sources, imports, markets, sells and licenses to certain licensees a variety of houseware and consumer electronic products, both domestically and internationally, under the Emerson brand name. The Company's core business consists of selling, distributing, and licensing various low and moderately priced houseware and consumer electronic products in various categories. Its products are Houseware Products consist Microwave Ovens, Compact Refrigerators, Toaster Ovens, Heaters and Fans; Audio Products consist Clock Radios, Bluetooth Speakers, Karaoke Machines, Wireless Charging; and Other consist Televisions, Security Products, Massagers. It operates in One segment. Majority of revenue comes from United States.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.